Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) is working on a consolidation plan for its manufacturing units, part of which includes selling its Ohm Labs manufacturing site based in New Jersey, reports CNBC-TV18. The US site has been put on sale a few months ago and is expected to fetch roughly $100 million. Some products are still being manufactured at the New Jersey site, which the company may either transfer or consider selling out to the unit's buyer.